Rivaroxaban para el tratamiento de la trombocitopenia inducida por heparina. Caso clínico

Heparin-induced thrombocytopenia (HIT) is immune-mediated. It occurs more frequently with unfractionated heparin (UFH) than with low molecular weight heparins (LMWH). It is associated with thromboembolic rather than hemorrhagic events, as opposed to thrombocytopenia of other etiologies. The key in t...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Rivera O.,Gustavo, Corsi S.,Oscar, Pavlovic J.,Andrés, Aizman S.,Andrés, Varas A.,Pablo
Lenguaje:	Spanish / Castilian
Publicado:	Sociedad Médica de Santiago 2017
Materias:	Abnormalities Drug-Induced Heparin Rivaroxaban Thrombocytopenia Thrombosis
Acceso en línea:	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872017000901213
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:scielo:S0034-98872017000901213
record_format	dspace
spelling	oai:scielo:S0034-988720170009012132017-12-07Rivaroxaban para el tratamiento de la trombocitopenia inducida por heparina. Caso clínicoRivera O.,GustavoCorsi S.,OscarPavlovic J.,AndrésAizman S.,AndrésVaras A.,Pablo Abnormalities Drug-Induced Heparin Rivaroxaban Thrombocytopenia Thrombosis Heparin-induced thrombocytopenia (HIT) is immune-mediated. It occurs more frequently with unfractionated heparin (UFH) than with low molecular weight heparins (LMWH). It is associated with thromboembolic rather than hemorrhagic events, as opposed to thrombocytopenia of other etiologies. The key in therapy is the cessation of heparin and the start of another anticoagulant. We report a 58 years old female with HIT secondary to the use of Enoxaparin who was successfully managed with Rivaroxaban. Our goal is to report a novel therapy and provide the evidence that supports its use.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.145 n.9 20172017-09-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872017000901213es10.4067/s0034-98872017000901213
institution	Scielo Chile
collection	Scielo Chile
language	Spanish / Castilian
topic	Abnormalities Drug-Induced Heparin Rivaroxaban Thrombocytopenia Thrombosis
spellingShingle	Abnormalities Drug-Induced Heparin Rivaroxaban Thrombocytopenia Thrombosis Rivera O.,Gustavo Corsi S.,Oscar Pavlovic J.,Andrés Aizman S.,Andrés Varas A.,Pablo Rivaroxaban para el tratamiento de la trombocitopenia inducida por heparina. Caso clínico
description	Heparin-induced thrombocytopenia (HIT) is immune-mediated. It occurs more frequently with unfractionated heparin (UFH) than with low molecular weight heparins (LMWH). It is associated with thromboembolic rather than hemorrhagic events, as opposed to thrombocytopenia of other etiologies. The key in therapy is the cessation of heparin and the start of another anticoagulant. We report a 58 years old female with HIT secondary to the use of Enoxaparin who was successfully managed with Rivaroxaban. Our goal is to report a novel therapy and provide the evidence that supports its use.
author	Rivera O.,Gustavo Corsi S.,Oscar Pavlovic J.,Andrés Aizman S.,Andrés Varas A.,Pablo
author_facet	Rivera O.,Gustavo Corsi S.,Oscar Pavlovic J.,Andrés Aizman S.,Andrés Varas A.,Pablo
author_sort	Rivera O.,Gustavo
title	Rivaroxaban para el tratamiento de la trombocitopenia inducida por heparina. Caso clínico
title_short	Rivaroxaban para el tratamiento de la trombocitopenia inducida por heparina. Caso clínico
title_full	Rivaroxaban para el tratamiento de la trombocitopenia inducida por heparina. Caso clínico
title_fullStr	Rivaroxaban para el tratamiento de la trombocitopenia inducida por heparina. Caso clínico
title_full_unstemmed	Rivaroxaban para el tratamiento de la trombocitopenia inducida por heparina. Caso clínico
title_sort	rivaroxaban para el tratamiento de la trombocitopenia inducida por heparina. caso clínico
publisher	Sociedad Médica de Santiago
publishDate	2017
url	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872017000901213
work_keys_str_mv	AT riveraogustavo rivaroxabanparaeltratamientodelatrombocitopeniainducidaporheparinacasoclinico AT corsisoscar rivaroxabanparaeltratamientodelatrombocitopeniainducidaporheparinacasoclinico AT pavlovicjandres rivaroxabanparaeltratamientodelatrombocitopeniainducidaporheparinacasoclinico AT aizmansandres rivaroxabanparaeltratamientodelatrombocitopeniainducidaporheparinacasoclinico AT varasapablo rivaroxabanparaeltratamientodelatrombocitopeniainducidaporheparinacasoclinico
_version_	1718436968342224896

Rivaroxaban para el tratamiento de la trombocitopenia inducida por heparina. Caso clínico

Ejemplares similares